Skip to Content

WPI 3704 (Armodafinil 200 mg)

Pill with imprint WPI 3704 is White, Capsule-shape and has been identified as Armodafinil 200 mg. It is supplied by Watson Laboratories, Inc..

Armodafinil is used in the treatment of narcolepsy; obstructive sleep apnea/hypopnea syndrome; shift work sleep disorder; chronic fatigue syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3704

Armodafinil

Imprint:
WPI 3704
Strength:
200 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
hypromelloses
magnesium stearate
corn starch
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide